At the Candiolo Cancer Institute, clinic and research professionals in oncology have experience and expertise attested by more than 1200 articles published in international scientific journals over the past 7 years and over 13000 citations other national and international researchers who have deemed our research worthy of consideration and of high scientific impact
1275 Scientific Publications
5119826 Total exams
530 staff
323 Researchers
The Institute is a leader in the activities of Hospitalization, Care and Research in the field of Oncological Diseases
The Institute is at the forefront of minimally invasive and robotic oncology surgery
The Institute's transplant centre, equipped with 4 controlled microclimate chambers, provides a multidisciplinary approach to oncological pathology.
The radiotherapy department is equipped with two tomo therapy devices and a state-of-the-art linear accelerator through which all cancers of adulthood are treated.
The Candiolo Institute as a national and international reference centre for the treatment and research of oncological diseases ensured the total take over from diagnosis to programming of therapies to follow-up strategies.
The programme of Hepatobiliary Pancreatic and Colorectal Surgery is dedicated to the diagnosis a
The programme of Hepatobiliary Pancreatic and Colorectal Surgery is dedicated to the diagnosis a
The Candiolo Institute has become a centre of reference for robotic surgery, through its acquisit
The Candiolo Institute has become a centre of reference for robotic surgery, through its acquisit
The work of the unit for Digestive Diagnostic and Surgical Endoscopy ( EDDI) is characterized by
The work of the unit for Digestive Diagnostic and Surgical Endoscopy ( EDDI) is characterized by
The Sarcomas and Rare Tumours Programme is dedicated to the diagnosis, treatment and follow-up of
The Sarcomas and Rare Tumours Programme is dedicated to the diagnosis, treatment and follow-up of
The aim of the Stem Cell Transplantation Programme is to offer patients suffering from the main o
The aim of the Stem Cell Transplantation Programme is to offer patients suffering from the main o
Capitalizing on this wealth of information, Traslational and Clinical Research are now revolutionizing the way we diagnose and treat cancer and offers unprecedented opportunities to improve the outlook of cancer patients on a rational basis.